menu search

Clearside biomedical to report third quarter 2023 financial results and provide corporate update on monday, november 13, 2023

ALPHARETTA, Ga., Oct. 31, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceut...

October 31, 2023, 11:05 am

Bioxcel therapeutics to report third quarter 2023 financial results on november 14, 2023

NEW HAVEN, Conn., Oct. 31, 2023 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceu...

October 31, 2023, 11:00 am

Kiniksa pharmaceuticals, ltd. (knsa) reports q3 loss, tops revenue estimates

Kiniksa pharmaceuticals, Ltd. (KNSA) came out with a quarterly loss of $0.20 per share versus the Zacks...

October 31, 2023, 10:32 am

Context therapeutics reveals ‘encouraging' preclinical data for ctim-76 tumor treatment

Context Therapeutics (NASDAQ:CNTX) Inc has announced what it called encouraging preclinical data regarding its preclinical asset, CTIM-76, a Claudin 6...

October 31, 2023, 10:12 am

Fulcrum therapeutics to host third quarter 2023 financial results conference call and webcast on tuesday, november 7, 2023, at 8:00 a.m. et

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage bio...

October 31, 2023, 8:50 am

Pph: a 'shot in the arm' for investors looking to capitalize on recent pharmaceutical advances

VanEck pharmaceutical ETF has had the strongest one-year performance of four major ...

October 31, 2023, 3:35 am

Epilepsy therapeutics market predicted to reach usd 14.9 bn by 2031 | exclusive report by transparency market research

Continuous R&D in second- and third-generation anti-epileptic drugs (AEDs) is anticipated to pave the way to new opportunities for ...

October 30, 2023, 9:30 pm

Amphastar pharmaceuticals (amph) laps the stock market: here's why

The latest trading day saw Amphastar pharmaceuticals (AMPH) settling at $45.19, representing a +1.23% c...

October 30, 2023, 7:34 pm

All you need to know about adial pharmaceuticals, inc. (adil) rating upgrade to buy

Adial pharmaceuticals, Inc. (ADIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optim...

October 30, 2023, 1:32 pm

Sanofi stock recovers slightly after last week's plunge

Sanofi (SNY) shares are trending higher after plummeting last Friday, after the pharmaceutical company ...

October 30, 2023, 11:39 am

Olema pharmaceuticals, inc. (olma) is a great choice for 'trend' investors, here's why

Olema pharmaceuticals, Inc. (OLMA) could be a great choice for investors looking to make a profit from ...

October 30, 2023, 10:33 am

Deciphera pharmaceuticals, inc. (dcph) reports q3 loss, tops revenue estimates

Deciphera pharmaceuticals, Inc. (DCPH) came out with a quarterly loss of $0.58 per share versus the Zac...

October 30, 2023, 9:46 am

Nexgel announces supply agreement with abbvie

NEXGEL (NASDAQ:NXGL) announced that its CG Converting and Packaging subsidiary has executed a supply agreement with bio...

October 30, 2023, 8:51 am

Why is conduit pharmaceuticals (cdt) stock up 66% today?

Conduit pharmaceuticals (NASDAQ: CDT ) stock is rocketing higher on Monday despite a lack of news from...

October 30, 2023, 8:39 am

Calibre scientific acquires cps analitica, a provider of chromatography consumables in italy

LOS ANGELES, Oct. 30, 2023 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of C.P.S. Analitica S.r.l. (“CPS” or the...

October 30, 2023, 8:00 am

Reviva pharma's schizophrenia drug succeeds in late-stage study

Reviva pharmaceuticals Holdings said on Monday its experimental drug to treat adults with schizophrenia...

October 30, 2023, 7:41 am

Kura oncology to participate in three upcoming investor conferences

SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceu...

October 30, 2023, 7:30 am

Neumora therapeutics to participate in upcoming conferences in november

WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage bio...

October 30, 2023, 7:00 am

Eton pharmaceuticals to report third quarter 2023 financial results on thursday, november 9, 2023

DEER PARK, Ill., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eton pharmaceuticals, Inc. (Nasdaq: ETON), an innova...

October 30, 2023, 6:50 am

Fennec pharmaceuticals to report third quarter 2023 financial results on november 6, 2023

RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Fennec pharmaceuticals Inc. (NASDAQ: FE...

October 30, 2023, 6:45 am


Search within

Pages Search Results: